STRAKOVÁ N., EHRMANN J., KOLÁŘ Z.:
PPARs & CANCER
|
41 |
MYSLIVEČEK M.1, BACOVSKÝ J.2, KAMlNEK M.1, KORANDA P.1, VYTŘASOVÁ M.2, HUSÁK V.1, ŠCUDLA V.2, NEKULA J.3:
TECHNETIUM-99m-MIBI SCINTIGRAPHY IN PATIENTS WITH MULTIPLE MYELOMA: ROLE OF THE EXAMINATION IN THE FOLLOW-UP AND ITS PROGNOSTIC VALUE
|
46 |
HŘIB R., HAKL M.:
RESULTS OF FEN-PAIN-1 OBSERVATIONIN ONCOLOGICAL PAIN: ANALYSIS AND CEMMENTARY
|
51 |
OC ADLÍKOVÁ D.1, KOVÁŘOVÁ L.1, PENK A M.1, ŽALOUDÍK J.4, BUCHLER T.1-2, HÁJEK R.124, MICHÁLEK J.1-3-4:
IDENTIFICATION OF TUMOR-SPECIFIC T CELLS BASED ON INTERFERON GAMMA PRODUCTIONIN MULTIPLE MYELOMA
|
55 |
SMEJKALOVÁ J.1, VRÁNOVÁ V.4, KOVÁŘOVÁ L.1, KUGLÍK P.4, FILKOVÁ H.3, HEINIGOVÁ J.1, ADAM Z.2, KREJČÍ M.2, BUCHLER T.1-2, KALÁBOVÁ V.2, OLTOVÁ A.3, VORLÍČEK J.2, PENKA M.1, HÁJEK R.1*2:
IMMUNOMAGNETIC SEPARATION OF BONE MARROW CELLS
IN MULTIPLE MYELOMA PATIENTS - DETECTION OF 13ql4 DELETION
USING INTERPHASE FLUORESCENCE IN SÍTU HYBRIDIZATION
|
59 |
HRSTKA R.1, MULLER P.1, VOJTÉŠEK B.1, NENUTIL R.2, STĚRlíA J.\ VALÍK D.4:
ANALYSIS OF CHANGESIN EXPRESSION OF p53 SIGNALLING GENES IN ACUTE LYMPHOBLASTIC LEUKEMIA CELLS AFTER METHOTREXATE TREATMENT
|
64 |
KOLLÁROVÁ H.1, ČÍŽEK L.1, KOUTNÁ J.2, BEŠKA F.3, LORENC J.3, JANOUT V.1:
SMOKING AND LUNG CANCER RISK BY HISTOLOGIC TYPE
|
69 |
